Gregory Scott Stein
Tulane University is actively seeking companies interested in commercializing novel constructs which effectively induce apoptosis in cancer cells. The novel approach employs two caspases to achieve a synergistic effect, resulting in a more substantial level of cell death in the targeted cancer cells.
This technology has been tested extensively in vitro and in vivo in a mouse model, with results strongly supporting the anti-cancer applications. Human trials are in development. Laboratory work is ongoing to produce more effective species of these constructs.
Tulane University, New Orleans, LA 70118 504-865-5000 email@example.com